Nicholas Fernandez

Jul 9, 2024 | nature.com | Nicholas Fernandez |Vijay Ramaswamy |Julie Bennett |Robert Siddaway |Uri Tabori

AbstractWith the success of immunotherapy in cancer, understanding the tumor immune microenvironment (TIME) has become increasingly important; however in pediatric brain tumors this remains poorly characterized. Accordingly, we developed a clinical immune-oncology gene expression assay and used it to profile a diverse range of 1382 samples with detailed clinical and molecular annotation.